Sarepta Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $54.4M
Liabilities Breakdown FY2011
Total Liabilities: $23.4M
Asset Breakdown
Total Assets: $54.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $39.9M | 73.4% |
| Accounts Receivable | $3.6M | 6.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.3M | 7.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $4.8M | 8.8% |
| Other Assets | $1.8M | 3.3% |
Liabilities Breakdown
Total Liabilities: $23.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.4M | 40.2% |
| Long-Term Debt | $1.8M | 7.5% |
| Other Liabilities | $12.2M | 52.2% |